TY - JOUR
T1 - Biological variation and analytical goals of four thyroid function biomarkers in healthy European volunteers
AU - Mairesse, Antoine
AU - Wauthier, Loris
AU - Courcelles, Louisiane
AU - Luyten, Urszula
AU - Burlacu, Maria Cristina
AU - Maisin, Diane
AU - Favresse, Julien
AU - van Dievoet, Marie Astrid
AU - Gruson, Damien
N1 - Publisher Copyright:
© 2020 John Wiley & Sons Ltd
PY - 2021/5
Y1 - 2021/5
N2 - Background: Interpretation of thyroid function tests by means of biological variation (BV) data is essential to identify significant changes between serial measurements at an individual level. Data on thyroid parameters in adults are limited. Objectives: We aimed at determining the BV of four thyroid function test (thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine (FT3) and thyroglobulin (Tg)) by applying recent recommendations to acquire BV data on a latest generation of immunoassay. Methods: Nineteen healthy volunteers (8 males and 11 females) were drawn every week during 5 consecutive weeks. Samples were analysed in duplicate on the Cobas 602 analyzer (Roche Diagnostics). After normality assessment, outlier exclusion and homogeneity of variance analysis, analytical variation (CVA), within-subject biological variation (CVI) and between-subject biological variation (CVG) were determined using nested ANOVA. Results: CVA, CVI and CVG were 0.9%, 19.7% and 37.6% for TSH; 3.6%, 4.6% and 10.8% for FT4; 2.2%, 6.0% and 8.6% for FT3; and 0.9%, 15.4% and 84.9% for Tg. Index of individuality (II) for all parameters was between 0.2 and 0.7. The percentage above which the change between two measures is truly significant (reference change value) was 54.7% for TSH, 16.2% for FT4, 17.7% for FT3 and 42.8% for Tg. Conclusion: Based on recent international recommendations, our study provides updated BV data for four thyroid function tests in European healthy volunteers. Reliable BV characteristics, and especially RCV, can facilitate the interpretation of consecutive thyroid function tests in an individual and therefore have the potential to efficiently support clinical decisions regarding thyroid diseases.
AB - Background: Interpretation of thyroid function tests by means of biological variation (BV) data is essential to identify significant changes between serial measurements at an individual level. Data on thyroid parameters in adults are limited. Objectives: We aimed at determining the BV of four thyroid function test (thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine (FT3) and thyroglobulin (Tg)) by applying recent recommendations to acquire BV data on a latest generation of immunoassay. Methods: Nineteen healthy volunteers (8 males and 11 females) were drawn every week during 5 consecutive weeks. Samples were analysed in duplicate on the Cobas 602 analyzer (Roche Diagnostics). After normality assessment, outlier exclusion and homogeneity of variance analysis, analytical variation (CVA), within-subject biological variation (CVI) and between-subject biological variation (CVG) were determined using nested ANOVA. Results: CVA, CVI and CVG were 0.9%, 19.7% and 37.6% for TSH; 3.6%, 4.6% and 10.8% for FT4; 2.2%, 6.0% and 8.6% for FT3; and 0.9%, 15.4% and 84.9% for Tg. Index of individuality (II) for all parameters was between 0.2 and 0.7. The percentage above which the change between two measures is truly significant (reference change value) was 54.7% for TSH, 16.2% for FT4, 17.7% for FT3 and 42.8% for Tg. Conclusion: Based on recent international recommendations, our study provides updated BV data for four thyroid function tests in European healthy volunteers. Reliable BV characteristics, and especially RCV, can facilitate the interpretation of consecutive thyroid function tests in an individual and therefore have the potential to efficiently support clinical decisions regarding thyroid diseases.
KW - biological variation
KW - Free T3
KW - Free T4
KW - reference change value
KW - thyroglobulin
KW - thyroid
UR - http://www.scopus.com/inward/record.url?scp=85101041637&partnerID=8YFLogxK
U2 - 10.1111/cen.14356
DO - 10.1111/cen.14356
M3 - Article
C2 - 33107075
AN - SCOPUS:85101041637
SN - 0300-0664
VL - 94
SP - 845
EP - 850
JO - Clinical Endocrinology
JF - Clinical Endocrinology
IS - 5
ER -